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Abstract
Purpose—We sought to understand the time course between exposure to manganese (Mn) and 
uptake into the blood, to allow a more meaningful interpretation of exposure-biomarker data, and 
determine the utility of blood as a biomarker of Mn exposure.
Methods—Welder trainees were monitored over the course of a five quarter training program. 
Each quarter, trainees gave eight blood samples and had personal air monitoring four times. A 
mixed model was fit to obtain estimates of airborne exposure by welding type (fixed effect), 
adjusted for subject (random effect). Considering weekends and days absent as zero exposure, 
estimated exposures were summed over various exposure windows, and related to measured blood 
manganese (MnB) using a mixed model.
Results—A relationship consistent with zero was found between MnB and modeled one or seven 
day exposure. After 30 days of preceding exposure, a one mg/m3-days increase in air Mn is 
associated with a 0.57 ng/mL increase in MnB (95% CI: −0.04, 1.19). Considering a 90 day 
exposure window and a cumulative exposure window a one mg/m3-days increase in air Mn is 
associated with a 0.26 (95% CI: 0.005, 0.51) and 0.09 (95% CI: 0.006, 0.17) ng/mL increase in 
MnB, respectively.
Conclusions—From this analysis, MnB may begin to act as a biomarker of Mn exposure over 
longer time periods, or at higher levels of exposure. This novel study design allowed investigation 
of how MnB relates to different time windows of exposure, representing the most robust Mn 
exposure assessment in the biomarker literature.
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INTRODUCTION
Exposure to manganese (Mn) has been implicated in manganism, a parkinsonian syndrome 
overlapping clinically with Parkinson’s Disease (PD), making Mn exposure assessment of 
interest to many public health professions (Antonini et al. 2006b; Aschner 2000; Calne et al. 
1994). One such tool for exposure assessment is biomonitoring—as this is often cheaper, 
easier, individual-specific, and may better estimate body dose as compared to traditional air 
monitoring techniques. Commonly, body fluids such as urine (Ellingsen et al. 2006; 
Järvisalo et al. 1992; Roels et al. 1987), whole blood (Ellingsen et al. 2006; Pesch et al. 
2012; Smith et al. 2007), plasma (Bowler et al. 2007; Grass et al. 2010), or serum (Chia et 
al. 1993; Myers et al. 2003) are used as biomarkers of exposure to Mn, but hair (Bader et al. 
1999; Rodrigues et al. 2008), toenails (Laohaudomchok et al. 2011; Sriram et al. 2012), and 
MRI (Baker et al. 2015a; Criswell et al. 2012) have also been explored in the literature as 
exposure biomarkers for Mn.
Ingested Mn is tightly regulated in the body (with the majority being eliminated via feces), 
and ambient environmental exposures are generally low. Thus, it is inhalation in 
occupational environments where excessive exposure to Mn usually occurs (Aschner et al. 
2005). Welding shops are one such occupational environment, with welders being exposed 
to eight hour mean personal breathing zone concentrations of Mn ranging from 0.04 mg/m3 
to over 2.0 mg/m3 based on the welding type, degree of enclosure, and use of ventilation and 
respiratory protection (Hobson et al. 2011). While Mn in welding fume deposited in the 
nasopharyngeal airways can reach the brain through direct olfactory transport, Mn also 
enters the circulatory system via the lung and crosses the blood brain barrier to reach the 
target organ (Antonini et al. 2006b; Tjalve and Henriksson 1999). However, timing of uptake 
from the lung into the blood is dependent on particle size distribution, solubility of the Mn 
compounds, concentration, and individual factors (Berlinger et al. 2008). Given the 
neurologic health effects associated with Mn in welding fume, it is reasonable to assume that 
after uptake, inhaled Mn is circulating in the blood prior to either elimination or crossing the 
blood brain barrier and reaching the target organ, making blood Mn (MnB) seem an 
attractive biomarker of Mn exposure (Aschner et al. 2007; Criswell et al. 2011; Racette et al. 
2005).
As a result, many studies have explored blood as a biomarker of Mn inhalation exposure, yet 
there is no clear consensus as to its utility and limitations. In previously published work, 
MnB levels appear to be fairly tightly regulated within an individual, and there is substantial 
between-individual variation, which could make interpretation of the relationship between 
blood Mn and Mn exposure challenging with a common cross-sectional study design (Baker 
et al. 2015b). It has been largely cross-sectional study designs that dominate the literature 
relating MnB and inhalation exposure. We reviewed the existing body of literature for 
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articles relating airborne Mn and MnB. We weighted the 29 studies included in the review 
by study size, and fit a segmented regression model. Our results showed that there appeared 
to be a positive linear relationship between MnB and airborne Mn when Mn exposure 
exceeded approximately 10μg/m3 (Baker et al. 2014). However, 26 of the 29 studies 
included in this review were cross-sectional, relating a single MnB and air measurement that 
might not have been taken at pharmacologically relevant (or even concurrent) time periods.
The pharmacokinetics of Mn in humans exposed to welding fume is not well established, 
with the current body of toxicology literature focusing on the pharmacokinetics related to 
primate or rodent exposure to compounds of Mn such as manganese chloride, manganese 
phosphate, or manganese sulfate. These chemicals differ from the Mn compounds known to 
predominate in a welding setting (Antonini et al. 2006b; Dorman et al. 2001; Vitarella et al. 
2000; Zheng et al. 2000). To explore the timing between Mn exposure, uptake, and health 
effects in an occupational setting, Antonini et al. developed a pharmacokinetic model using 
animals exposed to generated welding fume in a controlled chamber (2006a). In contrast, the 
current manuscript aims to explore the timing between exposure to Mn and possible changes 
in blood Mn in an occupational setting by utilizing longitudinal blood and air measurements 
from welder trainees. With repeat exposure measurements in a well-characterized cohort, we 
are able to determine subject specific estimates of exposure for each day the trainee was 
enrolled in our study, and then sum these estimates over different time windows of exposure 
for comparison with longitudinal MnB measurements. With repeat blood measurements for 
each subject, this manuscript also aims to examine the variance components exhibited in 
MnB. Understanding the time course between exposure to Mn and uptake into the blood will 
allow a more meaningful interpretation of exposure-biomarker data, and help to determine 
the utility of blood as a biomarker for Mn exposure.
METHODS
Occupational setting and study population
The study setting for this manuscript is a longitudinal inception cohort of 56 student welders 
with no prior occupational exposure to Mn, who were enrolled in a welding training 
program at a technical college in Washington state. Subjects were enrolled throughout the 
duration of the study, with data collection occurring from April 2011 to June 2013. Enrolled 
welding trainees were monitored for airborne exposure and MnB over the course of their 
training program. Details of the study design are described elsewhere (Baker et al. 2014). 
All study protocols were reviewed and approved by the University of Washington 
Institutional Review Board and subjects provided written informed consent.
The welding training program consisted of five academic quarters, with standard academic 
breaks in between, where students progressed through different welding processes in the 
order: oxyacetylene, shielded metal arc welding (SMAW), flux core arc welding dual shield 
(FCAW-DS), flux core arc welding inner shield (FCAW-IS), gas metal arc welding 
(GMAW), and gas tungsten arc welding (GTAW). The number of days spent on each process 
could vary between subjects. Students also intermittently did other metalworking tasks (i.e. 
cutting and/or grinding) which we characterized as a separate work category if that is what 
the welder reported doing for the majority of the day. Trainees were in the facility Monday 
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through Friday from about 8 AM to 2 PM, but time spent welding was interspersed with 
classroom instruction. Each welding booth in the facility had its own adjustable exhaust 
ventilation hood, and students were given the choice of whether or not to buy and wear 
respiratory equipment, which was not provided. There was no formal respiratory protection 
training or fit testing related to the traineeship.
Each quarter the subject was enrolled in the study a nurse drew 6 mL blood samples at the 
following times: the morning and afternoon of the first Monday and Friday of the quarter, 
and morning and afternoon on the last Monday and Friday of the quarter, for a potential 
eight blood samples each academic quarter. On each day that a subject provided blood 
samples, they were also fitted with a personal air pump for the duration of activity at the 
school to assess airborne exposure to Mn. At the end of each sampling day, subjects 
completed an exposure questionnaire to determine the type of welding done that day, the 
time spent welding, the use of any respiratory protection, and to assess any metalworking 
done outside of class time.
Blood Mn sampling and analysis
On mornings and afternoons of sampling days, 6 mL of whole blood was collected in plastic 
Vacutainer evacuated tubes containing 10.8 mg K2EDTA anticoagulant (BD, Franklin Lakes, 
NJ) and transported on ice to the American Industrial Hygiene Association (AIHA) 
Accredited University of Washington Environmental Health Laboratory (UW EHL) within 
two hours of collection. One mL of whole blood was pipetted into a 15 mL Corning 
CentriStar polypropylene centrifuge tube (Corning, NY), stored at 4 degrees C until multi-
element analysis of whole blood using an Agilent 7500 CE ICP-MS via microwave assisted 
acid digestion (Bocca et al. 2003). Over the course of the 26 month study, blood was 
submitted for analysis in 18 batches, but samples were randomly assigned to batches with 
regard to time of day, time of week, and time of quarter. The limit of detection (LOD) for 
Mn ranged from 0.1 – 2.0 ng/mL and is based on three times the standard deviation of the 
blanks. A total of 1170 blood samples were analyzed. No blood samples fell below the LOD 
for Mn. The slight variability in LOD is due to changing levels of blank contamination in the 
UW EHL over the 26 month time period that samples were submitted for analysis. Between 
batches, the percent recovery for Mn as compared to the control material (ClinChek Level 1 
Whole Blood Control, lyophilized for trace elements (Lot 038), Recipe Chemicals, Munich, 
Germany) ranged between 91% and 134% for all 18 batches with an overall average 
accuracy of 110% ± 12%. The average within batch variation in the control material was 
6.8% ± 6.1%.
Airborne Mn exposure assessment
On each sampling day (four days each academic quarter) the subject was enrolled in the 
study, they were fitted with a personal air pump (SKC AirChek XR4000, Eighty Four, PA, 
USA) with an attached pre-weighed 37mm 0.8μm pore mixed cellulose ester filter housed 
inside a closed face polystyrene cassette and hung on their collar outside the welding 
garments and helmet. The pumps were calibrated to 2.0 L/min, and this flow rate was 
checked at the beginning and end of each full-day sampling period. One sample had a ± 10% 
change in pump flow rate and was excluded. Filters were analyzed gravimetrically for total 
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particulate mass, digested in 10mL of a 1:1 mixture of concentrated nitric acid and deionized 
water using open vessel microwave assisted digestion, and analyzed at UW EHL for trace 
metals using an Agilent 7500 CE ICP-MS in He collision mode to eliminate polyatomic 
interferences. Samples were analyzed using the modified United States Environmental 
Protection Agency (US EPA) method 6020a Revision 1 (U.S. Environmental Protection 
Agency 1998). Each day of sampling included two field blanks, which were handled in the 
same manner as the samples deployed in the field. Over the course of the 26 month study, 
622 air samples were submitted for metals analysis in six batches, and were randomized 
with regard to time of week and time of quarter. Between batches, assay accuracy based on 
the spike recovery samples ranged between 88.0% and 110% with an overall average 
accuracy of 99.4 ± 7.2% for the six batches. The average within batch variation in the spiked 
samples was 8.2% ± 9.7%. Considering differences in pump flow rate and duration of 
sampling between the subjects, the maximum LOD for Mn was 0.13 μg/m3 μg, based on 
three times the standard deviation of the blanks deployed in the field. No air samples fell 
below the LOD for Mn.
Statistical analysis
Measured Mn air concentrations were normalized to 8-hr TWA Mn concentrations, and as 
the measured data were determined to be lognormal, the exposure samples were natural log-
transformed. A mixed model was fit to obtain estimates of exposure by welding type (fixed 
effect), adjusted for subject (random effect) on the log-transformed data. While enrolled in 
the welding program, attendance and progress records were used to determine days each 
subject was present and welding, and what type of welding the subject was doing each day. 
Thus, on each day a subject was present and welding, estimated subject-specific exposure 
based on the type of welding done that day was calculated. Weekends, vacation days, and 
days the subject was absent were coded as zero-exposure days. Thus, for each subject we 
generated a personal calendar of estimated Mn airborne exposure for each day they were 
enrolled in the welding program, based on attendance and type of welding. A total of 18,833 
day- and subject-specific exposure estimates were generated, including zero-exposure days. 
Results of the models on the ln-scale were used to calculate the subject- and day-specific 
arithmetic mean exposure by using maximum likelihood estimates, incorporating the within-
subject variance.
For each blood sampling day, we summed preceding exposures over various exposure 
windows: one day, seven day, 30 day, 90 day, and cumulative, which was a summation of all 
exposures from entry into the welding program until the day of the blood sample. All 
exposure windows are in units of mg/m3-days. The average number of exposed days 
represented by the cumulative exposure measure is 197 ± 142, ranging from 1 day (the 
minimum number of days of exposure on a subject’s first blood sample) to 805 days. About 
25% of cumulative exposure periods included in this mixed model represent time periods of 
less than 90 days. For afternoon blood samples, the same day estimated exposure counted in 
the exposure windows; for morning blood samples the previous day was counted as the first 
day of previous exposure.
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The associations between predicted exposures (for all five exposure windows) and measured 
MnB were assessed on the native scale using a longitudinal linear mixed-effects model 
including subject as a random effect. Several covariates were considered in the mixed 
models, including use of respiratory protection (based on self-reported percentage the 
subject used a respirator during sampling weeks), age at baseline, and smoking status, but 
none were found to affect the slope parameter of interest. Thus, reported models associating 
MnB and estimated exposure only include subject as a random effect with no additional 
fixed effect covariates. All presented models use only afternoon blood values in relation to 
preceding windows of exposure. Using morning blood values or the change in blood value 
over the course of a day did not affect the coefficients of association, and we wished to avoid 
making redundant models by modeling morning blood, afternoon blood, and the change in 
blood values over the course of a day in relation to preceding windows of exposure.
To directly compare the coefficients of association relating MnB to airborne Mn exposure 
over the five exposure windows despite each representing different durations of exposure, all 
point estimates from the linear mixed-effects models were normalized to a 30-day average 
exposure value (see equation 1). We standardized the effects to 3 mg/m3-days based on the 
American Conference of Industrial Hygienists (ACGIH) recommended 8-hr time weighted 
average threshold limit value (TWA TLV) for inhalable Mn of 0.1 mg/m3 over a 30 day 
exposure window, by multiplying 0.1 mg/m3 by 30 days in a month. Each estimated 
coefficient of association between MnB and air exposure for the various exposure windows 
was normalized to the value of 3 mg Mn/m3 over 30 days (for cumulative exposure we used 
the mean number of days representing a cumulative exposure, x=197) as:
Equation 1. 
Calculating 30 day normalized exposure for the exposure windows
x = length of the exposure window
βexp,x = coefficient of association between MnB and air exposure for the exposure window 
represented by x
RESULTS
Of the inception cohort, 52 of the 56 subjects were male (93%). The average subject was 28 
years of age at baseline, provided 21 blood samples (SD: 5.9, range: 1, 26) while enrolled in 
our study, and had 11 air samples (SD: 11.4, range: 4, 48). Only 25% of subjects (n=14) 
used a respirator more than 90% of the time.
Measured and predicted Mn exposures, along with blood values, are summarized by welding 
type in Table 1. The number of predicted exposure values for each welding type is fewer 
than the number of measured exposure values because only one predicted exposure value 
was generated for each welder for each welding type they completed while enrolled in our 
study. Thus, welders who did not complete a welding type do not have an estimated 
exposure value for that welding type. The arithmetic mean predicted values are similar to the 
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measured exposure values, though geometric mean values were more different. The 
measured exposure mean values are the means of all collected exposure values, whereas the 
predicted mean values are means of the individual mean levels. Thus, the within-subject 
variation has already been incorporated into the geometric mean value for the predicted 
exposure values, so the predicted values have higher geometric mean and lower GSDs 
relative to the measured exposure values.
Arithmetic mean MnB was highest during GTAW welding (9.6 ± 3.8 ng/mL) which is the 
last module welders complete in the program, but has some of the lowest measured Mn 
exposures (arithmetic mean: 5.5 ± 4.4 μg/m3). Arithmetic mean MnB was lowest during 
oxyacetylene welding (8.0 ± 3.0 μg/m3) which is the first welding module welders complete 
in the program, and would include most baseline MnB measurements. Oxyacetylene 
welding also represents the lowest measured airborne Mn exposure (arithmetic mean: 5.2 
± 3.1 μg/m3). The welding type with the highest measured Mn exposure was FCAW-DS, 
with arithmetic mean exposures of 40.7 ± 32.4 μg/m3. Only 3.4% of samples (n=21) exceed 
the ACGIH inhalable 8-hr TWA TLV of 0.1 mg/m3, and all measured exposures were below 
the Occupational Safety and Health Administration permissible exposure limit (OSHA PEL) 
for Mn in total inhalable dust of 5.0 mg/m3 (ceiling). Table 2 shows the predicted exposure 
estimates that were used in the longitudinal linear mixed models for all the time points 
considered in this analysis.
Table 3 shows descriptive statistics for MnB over the various time points, stratified by 
morning and afternoon samples. For paired samples, MnB tends to decrease over the course 
of a day, even when stratifying by time of week and time of quarter. A paired t-test found all 
but one of these decreases to be significantly different from zero. Despite these apparent 
decreases, using morning blood values or the change in blood value over the course of a day 
did not meaningfully affect the coefficients of association in any of the mixed models 
considered here. A linear mixed model including subject as a random effect was used to 
estimate differences in MnB over the course of a week and quarter, stratified by time of day. 
The results are also reported in Table 3. MnB tended to decrease over the course of a week 
for both morning and afternoon samples (though only significantly different from zero in 
afternoon samples), and didn’t show a change different from zero over the course of a 
quarter for either morning or afternoon samples.
Table 4A shows the estimated coefficients of association between predicted exposure over 
the various time windows and MnB measured in the afternoon. Table 4B shows these 
coefficients standardized to a 30-day exposure period. Afternoon MnB showed no 
relationship with that day’s exposure, or the preceding seven or 30 days of exposure. 
However, when considering the preceding 90 days exposure, a slight relationship emerges, 
with a one mg/m3-days increase in air Mn being associated with, on average, a 0.26 ng/mL 
increase in MnB (SE: 0.13, 95% CI: 0.005, 0.514). Similarly, when considering all 
preceding exposures (cumulative exposure) a one mg/m3-days increase in air Mn is 
associated with, on average, a 0.09 ng/mL increase in MnB (SE: 0.04, 95% CI: 0.005, 
0.174). Standardized to a 30-day exposure period, a 3 mg/m3 increase in 90 day Mn 
exposure is associated with a 2.34 ng/mL average increase in MnB (SE: 1.17, 95% CI: 
0.049, 4.63), and a 3 mg/m3 increase in cumulative exposure is associated with an average 
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increase in MnB of 1.77 ng/mL (SE: 0.85, 95% CI: 0.125, 3.44). Figure 1 demonstrates the 
increasing relationship between MnB and exposure over longer time periods or higher levels 
of cumulative exposure when considering these standardized coefficients.
Variance components are also presented in Table 4A, and it can be seen that for all exposure 
windows considered the majority of variance is between subjects. This was similar to what 
was found in our previous work on a more restricted sample of subjects from this cohort 
(Baker et al. 2015b).
DISCUSSION
The longitudinal study design presented here allowed investigation of relationships between 
measured MnB and modeled inhalation exposures occurring over different time windows, 
the first time such work has been presented in the literature. With this analysis, we found 
that when considering the preceding 30 days of exposure, a one mg/m3-days increase in air 
Mn is associated with, on average, a 0.57 ng/mL increase in MnB (95% CI: −0.04, 1.19), but 
this estimate is still consistent with a zero slope. However, when considering a 90 day 
preceding exposure window, and a cumulative exposure window, a one mg/m3-days increase 
in air Mn is associated with a 0.26 (95% CI: 0.005, 0.51) and 0.09 (95% CI: 0.006, 0.17) 
ng/mL increase in MnB, respectively, both results that were found to be significantly 
different from a zero slope.
Point estimates for all the exposure windows (one day, seven day, 30 day, 90 day, 
cumulative) were normalized to a 3mg/m3-days exposure. This exposure was based on 30 
days of exposure at the ACGIH recommended 8-hr TWA TLV for inhalable Mn of 0.1 
mg/m3. Upon normalizing the point estimates, an increasing trend emerged when looking at 
the relationship between afternoon MnB and summed exposures in the preceding seven, 30, 
and 90 day exposure windows. Though the coefficients for one, seven, and 30 day exposure 
windows were consistent with a zero slope, when considering the 90 day exposure window a 
3 mg/m3-days increase in exposure over a 30 day period was consistent with a 2.34 ng/mL 
increase in MnB (SE: 1.17, 95% CI: 0.049, 4.63). Cumulative exposure also maintained a 
significant increase in MnB, with a 3 mg/m3-days increase in exposure over a 30 day 
window being consistent with a 1.77 ng/mL increase in MnB (SE: 0.85, 95% CI: 0.13, 3.44).
This relationship between MnB and Mn air exposure at higher accumulated levels of 
exposure (which would occur after a longer time of exposure) is consistent with what was 
presented in our previous review relating measures of MnB and Mn exposure with mostly 
cross-sectional data from the literature. In that meta-analysis, when weighting by study size 
and fitting a segmented regression, the relationship between MnB and Mn exposure became 
apparent after a certain threshold of exposure was reached, at about 10 μg/m3 (Baker et al. 
2014). Similarly, Pesch et al. (2012) found that measured MnB seemed to relate to measured 
respirable Mn in air at around 50–100 μg/m3, below which no obvious correlation was 
present. However, both our review and the work by Pesch et al. found associations between 
MnB and exposure at lower levels of exposure than we found in this study, as we didn’t see 
an apparent relationship until after 30 days of accumulated exposure, and the mean value 
used in our model for a 30 day accumulated exposure window was about 420 μg/m3-days. 
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However, models presented in this paper are specific to accumulated exposure and duration 
of exposure, whereas our review paper and the work by Pesch et al. are specific to daily 
exposure estimates. As such, neither our review nor the work by Pesch et al. took into 
account the temporal aspects between air exposure and blood uptake, or used a cumulative 
measure of exposure for different time periods, which was done in this study, thanks to our 
ability to quantify temporal resolution with our longitudinal study design. Also, as subjects 
in our study were welding trainees with no previous occupational exposure to Mn, the delay 
before seeing a relationship between blood Mn and predicted airborne Mn could also be due 
to the time necessary for the blood Mn to reach a steady state in the trainees. With career 
welders or in persons with long term, consistent exposure to Mn, the relationship between 
blood Mn and air Mn could manifest sooner, or stronger.
Creating exposure windows based on subject-specific estimates and their personal calendar 
of exposure is a powerful method to extrapolate the timing between exposure to Mn and its 
potential uptake into blood. This method could only be utilized because of the longitudinal 
measurements collected on the subjects, and the detailed information available on their daily 
tasks and attendance. The mixed model fit allowed creation of unique exposure estimates for 
each enrolled subject, and for each type of welding they did in the program. The exposure 
assessment done for this study represents the most robust exposure assessment for any study 
relating MnB and inhalation exposure to Mn. Using a mixed model including subject as a 
random effect means the data presented here is essentially the average of all individual 
trends observed in these data. Therefore, even though the models aren’t predicting on an 
individual basis, they are controlling for inter-subject variation, thus making this 
substantially different from a repeated-measures design that does not control for within 
subject trends.
When looking at the variance components related to the relationship between afternoon 
MnB and seven day, 30 day, 90 day, and cumulative exposure time windows the majority of 
variance (61%) was found to be between individuals. Even more of the total variance (71%) 
was between individuals when assessing the relationship between afternoon MnB and the 
preceding one day of exposure. This supports our previous work, where the majority of 
variance in MnB levels in a subset of the apprentice welders was between individuals (94%) 
and only about 6% of the total variance was within an individual (Baker et al. 2015b). Thus, 
in that subcohort, Mn seemed to be fairly tightly regulated in the blood, and the high degree 
of between-subject variation in MnB was due to differences in individual biochemistry and 
baseline MnB, and not due to exposure duration or accumulation. However, this previous 
work only looked at a subset of the total welding cohort presented in this analysis (n=9 
subjects), and analyses were restricted to only their first academic quarter of study in the 
apprentice training program, a time period of approximately 70 days with relatively low 
levels of exposure. Thus, it is logical that in this current study, which looks at some longer 
durations of exposure, there would be more variation within a subject as the tight regulation 
of Mn in the blood may be overcome due to increased exposure duration. Compared to the 
previous work, in this study there was an increase in total variance, and in particular, a 
greater proportion of the total variance was within a subject. This increase in within-subject 
variance, coupled with the relationship we began to see between MnB and modeled 
exposure in longer exposure windows, drives the conclusion that MnB may serve as a 
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biomarker of exposure to Mn, but only over longer time periods, such that the tight 
regulatory control of Mn in the blood is perturbed. As shown in previous studies (Apostoli et 
al. 2000; Bader et al. 1999), due to its high inter-individual variance, MnB is a biomarker 
that should be used to differentiate groups by exposure status, rather than for the 
characterization of the exposure of individuals.
Interestingly, measured MnB exhibited a mean decrease over the course of a day, even when 
stratifying by time of week and time of quarter. Generally, these decreases were statistically 
different from zero. This finding was contrary to what was expected to be seen a priori; it 
was assumed an increase in MnB would be present over the course of a day as exposure 
increased. Taking urine samples every four hours for a 24 hour period from welders, 
Jarvisalo et al. found a diurnal variation of Mn in urine, with higher urine Mn values found 
in the morning compared to in the afternoon or evening (Järvisalo et al. 1992). Given the 
burden to subjects in collecting serial blood samples in a similar manner, diurnal variability 
has not been established for MnB in humans, though seems a plausible hypothesis. In this 
study, of the 557 paired blood samples taken on a given day, 37% (n=204) exhibited an 
increase in MnB over the course of a day, wheras 63% (n=353) exhibited a decrease in MnB 
over the course of a day. Diurnal variability could explain the apparent decrease observed in 
MnB over the course of a day, and changes in the type of welding being done over the 
course of a week or quarter (for example, moving from a high exposure welding practice to a 
low exposure welding practice) could explain some of the decreases observed over long time 
periods in these data. However, other pharmacokinetic reasons may explain the changes seen 
over the course of a week and academic quarter (even when controlling for time of day) 
which would require further investigation.
The existing body of literature that has explored blood as a biomarker of Mn exposure has 
employed largely cross-sectional study designs, often trying to relate a single blood and 
exposure measurement collected on the same day (Baker et al. 2014). The results presented 
here show that a cross-sectional approach to assess the utility of blood as a biomarker of Mn 
would not be ideal, since a single blood sample is likely representing exposures accumulated 
over a longer preceding time period (at least 30 days) not over the sampled work shift. The 
longitudinal study design and subject-specific exposure modeling allowed the exploration of 
different time windows of exposure and changes in individual MnB levels over time, which 
is an improvement over the existing body of literature and can provide more insight into the 
biochemical properties (and time course) of inhaled Mn in welding fume.
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Figure 1. 
Effect estimate of exposure windows
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